Care Facility Financing

 

Ocean Pacific Capital aims to finance America’s hospitals and care facilities. We offer the best care facility financing. Since 1977, we have access to over 130 different lenders supporting the development of thousands of communities across the United States insuring hospital mortgages and care facilities. Clients may range from small rural care facilities to some of the U.S.’s top urban hospitals. The better the credit rating offered by the United States government (AA to AAA rating), the lower the interest rate, which equates to more spending power to address community needs. These loans are available to care facilities in all 50 states and territories, for-profit, non-profit, and government-owned care facilities. We offer care facility financing for refinancing, remodeling, expansion, construction financing, and modernization. Our streamlined application process is available with reduced documentation. Loan values can range from $500,000 to $50 million plus and loan-to-value ratio of up to 90%. Fixed rate and adjustable rate loans are available for new construction or rehabilitation loan and can be amortized over 20-40 years. We offer competitive fixed and adjustable rates for all terms, 10,20, 25, 30, 35, and 40 years. We also offer competitive rats for acquisitions, refinances, and constructions of assisted living facilities, skilled nursing, and other specialty care facilities.

Ocean Pacific Capital’s professional staff has the experience to answer all of your questions and to assist you throughout the loan process with unparalleled customer service. Call us or email us today so we can immediately help with your care facility financing needs!

WSJ.com: US Business

Shell Plans to Drill in Gulf of Mexico Despite Climate and Political Debate
The European oil giant is investing billions of dollars in the Gulf even as the Biden administration sends mixed signals on the future of drilling there.

Rajeev Misra to Step Back From Top Executive Role at SoftBank
Misra, who runs SoftBank?s giant venture-investing arm, plans to run a new outside investment outfit, according to a company memo.

Merck Is in Advanced Talks to Buy Cancer Biotech Seagen
A deal, potentially worth $40 billion or more, would help Merck broaden its lineup of cancer drugs, currently led by Keytruda.

Memory-Chip Prices Fall From Pandemic Highs
The average contract price for a major type of memory fell by 10.6% in the second quarter and prices are expected to decline even more in the coming months.

Senate Report Hits AbbVie's Bermuda Tax Structure for U.S. Humira Sales
Company made most of its overall 2021 sales in the U.S. while recording most of its profits in foreign subsidiaries, leaving it with a tax bill far below the 21% U.S. rate.

Inflation Fears Drove Larger Fed Rate Increase
Fed officials concluded last month they needed to raise rates faster and to levels high enough to slow the economy because of the worsening inflation picture.

Hiring Demand Remained Strong in May
Demand for workers remained robust in late spring, with May job openings and the number of times workers quit their jobs declining but remaining historically high.